Literature DB >> 19373750

Gender-related differences in pituitary adenomas.

B D Arasho1, B Schaller, N Sandu, G Zenebe.   

Abstract

Pituitary adenomas account for about 10% of all intracranial neoplasms and for about 85% of all pituitary tumors. In addition, prospective studies of normal persons and postmortem examinations reveal pituitary adenomas in up to 10% of adults indicating that not all pituitary adenomas are clinically significant. With clinically significant pituitary adenomas, patients may present with hyper- or under-secretion of pituitary hormones or with symptoms and signs of space occupying intracranial tumor like headache and visual compromise. Like other differentiated neuroendocrine cells, the anterior pituitary displays remarkable plasticity in response to physiological demands, as exemplified by the lactotroph differentiation and proliferation of pregnancy or the thyrotroph hyperplasia of primary hypothyroidism. These reversible changes are mediated by a diverse array of signals that have been interpreted to support a role for hormonal stimulation in the pathogenesis of pituitary adenomas. Different investigators have shown a tendency to gender-related differences not only in surgical outcome, but also in the presenting symptoms and signs, duration of symptoms, tumor size, tumor histology, and restoration of normal pituitary function in patients who are surgically treated and histologically proven pituitary adenomas. In this review, we will try to give a systematic insight into gender related differences of pituitary adenomas. Special reference is given on potential different biology of these tumors as suggested by the gender related differences. The manuscript therefore gives new insights into the cellular understanding of the pituitary adenomas. Copyright J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart . New York.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19373750     DOI: 10.1055/s-0029-1202831

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  8 in total

1.  Comparison of Male and Female Prolactinoma Patients Requiring Surgical Intervention.

Authors:  Frederick Yoo; Carmen Chan; Edward C Kuan; Marvin Bergsneider; Marilene B Wang
Journal:  J Neurol Surg B Skull Base       Date:  2017-12-26

2.  Molecular imaging of stem cell therapy in brain tumors: a step towards personalized medicine.

Authors:  Nora Sandu; Bernhard Schaller
Journal:  Arch Med Sci       Date:  2012-09-08       Impact factor: 3.318

3.  Surgical management of growth hormone-secreting pituitary adenomas: A retrospective analysis of 33 patients.

Authors:  Yong Zheng; Dong-Ming Chen; Yan Wang; Rong-Kang Mai; Zi-Feng Zhu
Journal:  Medicine (Baltimore)       Date:  2020-05       Impact factor: 1.889

4.  Incidence of heart valve disease in women treated with the ergot-derived dopamine agonist bromocriptine.

Authors:  Marianne F Clausen; Rasmus Rørth; Christian Torp-Pedersen; Lucas Malta Westergaard; Peter E Weeke; Gunnar Gislason; Lars Køber; Emil Fosbøl; Søren Lund Kristensen
Journal:  BMC Cardiovasc Disord       Date:  2021-12-28       Impact factor: 2.298

5.  Intrasellar pressure in patients with pituitary adenoma - relation to tumour size and growth pattern.

Authors:  Gabriel Simander; Per Olof Eriksson; Peter Lindvall; Lars-Owe D Koskinen
Journal:  BMC Neurol       Date:  2022-03-09       Impact factor: 2.474

6.  Functional Outcome Changes in Surgery for Pituitary Adenomas After Intraoperative Occurrence of the Trigeminocardiac Reflex: First Description in a Retrospective Observational Study.

Authors:  T Chowdhury; C Nöthen; A Filis; N Sandu; M Buchfelder; Bernhard Schaller
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

Review 7.  Successful management of octreotide-insensitive thyrotropin-secreting pituitary adenoma with bromocriptine and surgery: A case report and literature review.

Authors:  Chengxian Yang; Huanwen Wu; Jing Wang; Mingming Hu; Xiaoping Xing; Xinjie Bao; Renzhi Wang
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889

8.  The functional evaluation of pituitary in patients with a surgical resection of sellar tumours.

Authors:  Zehao Liu; Huan Zhang; Sha Liu; Huiling Chen
Journal:  Arch Med Sci       Date:  2019-10-29       Impact factor: 3.318

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.